首页> 外国专利> Injectable compositions containing the Association quinupristin / dalfopristin.These compositions with Double Compartment for lapreparacion of perfusion Solution containing the AssociationThe buffer solution used in these compositions and suutiliza injecting

Injectable compositions containing the Association quinupristin / dalfopristin.These compositions with Double Compartment for lapreparacion of perfusion Solution containing the AssociationThe buffer solution used in these compositions and suutiliza injecting

机译:含有奎奴普丁/达福普汀协会的可注射组合物,这些组合物具有双重隔室,用于灌注灌注液,包含协会缓冲液用于这些组合物和suutiliza注射

摘要

Injectable compositions are disclosed which contain / quinupristin and dalfopristin Association comprising an aqueous solution that contain quinupristin / dalfopristin and an Additive Association desIn order to avoid or reduce the effects of intolerance at the injection site.These compositions also are described, with Double Compartment for the preparation of the solution for infusion containing dichaasociacion,The buffer solution used in these injectable compositions and their use for the preparation of a Medicament, and to the Presentation of these injectable compositions.Finally describes the Kit presentation of such Pharmaceutical compositions.
机译:为了避免或减少注射部位的不耐受作用,公开了含有奎奴普丁和达福普汀协会的可注射组合物,其包含含有奎奴普丁/达福普汀的水溶液和添加剂协会。用于制备含有双甲硫龙的输液的溶液,在这些可注射组合物中使用的缓冲溶液及其在制备药物中的用途以及这些可注射组合物的展示。最后描述了这种药物组合物的试剂盒展示。

著录项

  • 公开/公告号AR017875A1

    专利类型

  • 公开/公告日2001-10-24

    原文格式PDF

  • 申请/专利权人 MONARCH PHARMACEUTICALS IRELAND LIMITED;

    申请/专利号ARP980106416A

  • 发明设计人

    申请日1998-12-16

  • 分类号A61K9/08;A61K31/33;A61K31/71;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号